Skip to main content
. 2015 Jun 10;15:464. doi: 10.1186/s12885-015-1482-8

Fig. 1.

Fig. 1

Enhanced cytotoxicity of AdF35/MK. Viability of esophageal carcinoma cells that were treated with various doses of Ad5/MK, AdF35/MK, Ad5/LacZ or AdF35/LacZ was examined with the WST assay. The relative viability was calculated based on the absorbance without any treatments. Standard errors (SE) bars are shown (n = 3). *P < 0.01; comparing between Ad5/MK- or AdF35/MK-infected cells and Ad5/LacZ- or AdF35/LacZ-infected cells